This article is available to subscribers. Subscribe now. Already have an account? Sign in

A correction has been published 1

Original ArticleFree PreviewArchive

Myocardial Salvage after Intracoronary Thrombolysis with Streptokinase in Acute Myocardial Infarction — Assessment by Intracoronary Thallium-201

List of authors.
  • John E. Markis, M.D.,
  • Michael Malagold, M.D.,
  • J. Anthony Parker, M.D.,
  • Kenneth J. Silverman, M.D.,
  • William H. Barry, M.D.,
  • Ann V. Als, M.D.,
  • Sven Paulin, M.D.,
  • William Grossman, M.D.,
  • and Eugene Braunwald, M.D.

Abstract

Nine patients with acute myocardial infarction had cardiac catheterization and intracoronary infusions of streptokinase 2.3 to 4.3 hours (mean, 3.5) after the onset of symptoms. Occluded coronary arteries were opened within approximately 20 minutes in all patients, but reocclusion occurred in one patient. The immediate effect of thrombolysis on myocardial salvage was assessed with the intracoronary injection of thallium-201. Improved regional perfusion, indicating myocardial salvage after recanalization, was observed in seven of the nine patients. One patient, who had also sustained a nontransmural infarction one week before, had no change after thrombolysis. In the ninth patient, recanalization of a coronary artery was followed by reocclusion and worsening of the myocardial-perfusion defect. Intracoronary thallium-201 studies two weeks and three months after streptokinase infusion in two patients were unchanged in comparison with scintiscans performed 1.5 hours after thrombolysis. These short-term observations suggest that recanalization of obstructed coronary arteries after intracoronary thrombolysis can salvage jeopardized myocardium. However, evaluation of the long-term effects of this procedure on survival and myocardial function will require controlled clinical trials. (N Engl J Med. 1981; 305:777–82.)

Funding and Disclosures

Supported in part by a grant (CG 81010) from the New England Nuclear Corporation.

Dr. Parker is the recipient of a Research Career Development Award (IK04 HL 00465) from the National Heart, Lung, and Blood Institute.

We are indebted to Ellen Duffy, R.N., Susan Schofield, Peter Sahagian, and Drs. John Aumiller, John Dervan, Josef Cherniles, and John Marais for their assistance; to Drs. William Ganz, Garrett Lee, and Lawrence Reduto for their advice; and to Kathleen Tynan for her help in preparing the manuscript.

Author Affiliations

From the Charles A. Dana Research Institute and the departments of Medicine and Radiology and Thorndike Laboratory, Beth Israel Hospital and Harvard Medical School, Boston. Address reprint requests to Dr. Markis at the Cardiovascular Division, Beth Israel Hospital, 330 Brookline Ave., Boston, MA 02215.